168 related articles for article (PubMed ID: 3290999)
1. [Clinical trial of local immunomodulation with DNCB in cases of advanced melanoma of the skin].
Budzanowska E; Pawlicki M
Przegl Dermatol; 1988; 75(1):29-34. PubMed ID: 3290999
[No Abstract] [Full Text] [Related]
2. Immunosurgical approach to the treatment of malignant melanoma using 2,4-dinitrochlorobenzene (DNCB).
Lukács L; István M
Neoplasma; 1984; 31(4):437-45. PubMed ID: 6472514
[TBL] [Abstract][Full Text] [Related]
3. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
4. [Decrease in immunoreactivity in melanoma. Analysis of DNCB tests in the literature].
Remy W; Dorn R; Ulm K; Mayerhausen W
Z Hautkr; 1986 Dec; 61(24):1767-77. PubMed ID: 3825218
[TBL] [Abstract][Full Text] [Related]
5. [The nonspecific epifocal Malek-Mansour immunotherapy of malignant cutaneous melanoma using DNCB].
Illig L; Paul E
Hautarzt; 1976 Dec; 27(12):579-87. PubMed ID: 1010745
[TBL] [Abstract][Full Text] [Related]
6. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
[TBL] [Abstract][Full Text] [Related]
7. [Vaccination therapy of melanoma].
Schuler-Thurner B; Schuler G
J Dtsch Dermatol Ges; 2005 Aug; 3(8):630-45. PubMed ID: 16033483
[No Abstract] [Full Text] [Related]
8. [Results of the treatment of advances melanoma of the skin with high daily doses of dacarbazine].
Klimek M; Pawlicki M
Przegl Lek; 1988; 45(6):543-5. PubMed ID: 3075309
[No Abstract] [Full Text] [Related]
9. Clinical trials referral resource. Melanoma.
Cheson BD
Oncology (Williston Park); 1991 Jun; 5(6):95, 98, 101. PubMed ID: 1831644
[No Abstract] [Full Text] [Related]
10. [DNCB immunotherapy for removal of melanoma skin metastases].
Wätzig V
Dermatol Monatsschr; 1977 Oct; 163(10):848-50. PubMed ID: 923876
[No Abstract] [Full Text] [Related]
11. [New aspects of immunotherapy of malignant melanoma].
Enk A
Praxis (Bern 1994); 2001 Mar; 90(10):403-6. PubMed ID: 11305186
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant application of interferons.
el Kassas H; Kirkwood JM
Semin Oncol; 1996 Dec; 23(6):737-43. PubMed ID: 8970596
[No Abstract] [Full Text] [Related]
13. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P
Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859
[TBL] [Abstract][Full Text] [Related]
14. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
Agarwala SS; Neuberg D; Park Y; Kirkwood JM
Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant DNCB immunotherapy in malignant melanoma].
Weidner F; Djawari D
Z Hautkr; 1979 May; 54(10):436-43. PubMed ID: 473840
[TBL] [Abstract][Full Text] [Related]
16. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB
Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815
[No Abstract] [Full Text] [Related]
17. [Preliminary results of immuno-surgical treatment of primary melanoma (author's transl)].
Vanwicjk R; Rustin P; Malek-Mansour S; Castermans-Elias S; Castermans A
Acta Chir Belg; 1975 Jul; 74(4):430-40. PubMed ID: 1146463
[TBL] [Abstract][Full Text] [Related]
18. [Contribution to treatment of malignant melanoblastoma by the local application of DNCB (author's transl)].
Duchková H; Richter J; Kubíková M
Cesk Dermatol; 1978 Jun; 53(3):169-72. PubMed ID: 679282
[No Abstract] [Full Text] [Related]
19. Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
Rangel DM; Golub SH; Morton DL
Surgery; 1977 Aug; 82(2):224-32. PubMed ID: 877866
[TBL] [Abstract][Full Text] [Related]
20. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
